Access cutting-edge blood glucose treatment through this clinical trial at a research site in West Lafayette. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this West Lafayette location
Preparing your pre-screening questions…
Access blood glucose specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related blood glucose treatment provided free
Check if you qualify for this blood glucose clinical trial in West Lafayette, IN
No-Cost Study Care
Local to West Lafayette
Convenient for IN residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The goal of this clinical trail is to learn if the hormone, glucagon-like peptide-1 (GLP-1), is stimulated by slowly digestible carbohydrates (SDCs) in healthy adults. In the current study, researchers will observe the amount of SDC that results in clinically meaningful levels of GLP-1, shown by an increase in feelings of fullness and a decrease in hunger, and how long an elevated level of GLP-1 lasts after starch consumption. Researchers aim to address two questions: What amount of SDC maximizes GLP-1-mediated satiety, and does the impact to satiety continue in a second meal? The overall goal is to maximize ileal-digesting SDC's potential use as a food-based agent for weight loss. Researchers will compare 20, 40, and 60 g of raw corn starch compared to a maltodextrin control on total plasma GLP-1 concentrations, insulin, and blood glucose at baseline and 15, 30, 60, 90, 120, and 180 minutes post-consumption of SDC. Researchers will also measure satiety at baseline, 60, 120, 180 minutes and after a second meal. There will be a total of 4 study visits with a least a 7-day break between visits. At each study visit, participants will: * Consume a randomized test beverage (SDC or maltodextrin) * Receive a blood draw at 7 timepoints over 3 hrs * Take a satiety questionnaire 5 times over 3 hrs * Consume a standardized lunch 3 hrs after the test beverage consumption
Sponsor: Purdue University
Yes, this clinical trial (NCT07572513) has an active research site in West Lafayette, IN that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for blood glucose treatment options in West Lafayette, IN, this clinical trial (NCT07572513) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our West Lafayette research site is actively enrolling participants for this clinical trial. You'll receive care from experienced blood glucose specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all blood glucose clinical trials near you to find additional studies recruiting in your area.
See all ulcerative colitis clinical trials recruiting in West Lafayette — not just this study.
Browse Ulcerative Colitis Trials in West Lafayette →